Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (10): 1020-1025    DOI: 10.19485/j.cnki.issn2096-5087.2022.10.010
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
1990—2019年浙江省心血管疾病负担变化趋势
林永兴1,2, 刘足云2, 李娜3, 于村1
1.浙江省疾病预防控制中心综合保障部,浙江 杭州 310051;
2.浙江大学,浙江 杭州 310058;
3.浙江省疾病预防控制中心,浙江 杭州 310051
Changing trends in burden of cardiovascular diseases in Zhejiang Province from 1990 to 2019
LIN Yongxing1,2, LIU Zuyun2, LI Na3, YU Cun1
1. Department of Intergrated Support, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China;
2. Zhejiang University, Hangzhou, Zhejiang 310058, China;
3. Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China
全文: PDF(1630 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解1990—2019年浙江省心血管疾病(CVD)负担变化趋势,为全省CVD防控工作提供依据。方法 通过2019年全球疾病负担研究(GBD 2019)数据库,收集1990—2019年浙江省CVD导致的伤残损失健康寿命年(YLD)、早死损失寿命年(YLL)和伤残调整寿命年(DALY)资料,采用YLD率、YLL率和DALY率评价CVD疾病负担;计算年度变化百分比(APC)分析CVD疾病负担变化趋势,并与全国及全球不同社会人口学指数(SDI)地区比较。结果 1990—2019年浙江省CVD导致的YLL率(APC=-0.50%,F=22.366,P<0.001)和DALY率(APC=-0.20%,F=5.212,P=0.030)呈下降趋势,YLD率呈上升趋势(APC=1.92%,F=1 117.891,P<0.001)。女性CVD导致的YLL率(APC=-1.09%,F=56.871,P<0.001)、YLD率(APC=1.92%,F=922.541,P<0.001)和DALY率(APC=-0.60%,F=28.974,P<0.001)变化趋势与全人群一致;男性仅YLD率变化显著,呈上升趋势(APC=1.82%,F=1 238.423,P<0.001)。各年龄组YLL率和DALY率均呈下降趋势,其中50~<70岁人群下降最明显(APC=-4.40%,F=1 443.608,P<0.001;APC=-3.82%,F=1 519.452,P<0.001)。各类型心血管病中脑血管病负担最重,标化DALY率为1 359.7/10万,风湿性心脏病导致的标化DALY率下降最明显。浙江省CVD疾病负担低于全国及全球多数地区,变化趋势与全国及全球各类SDI地区一致。结论 1990—2019年浙江省CVD疾病负担整体呈下降趋势,与全国及全球各类SDI地区一致;女性、50~<70岁人群、风湿性心脏病的疾病负担下降较为明显。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
林永兴
刘足云
李娜
于村
关键词 心血管疾病疾病负担伤残调整寿命年伤残损失健康寿命年早死损失寿命年    
AbstractObjective To investigate the changing trends in the burden of cardiovascular diseases (CVD) in Zhejiang Province from 1990 to 2019, so as to provide insights into CVD control in the province. Methods Based on the data of the Global Burden of Disease Study (GBD) 2019 (GBD 2019), the years lived with disability (YLD), years of life lost (YLL), disability-adjusted life years (DALY), YLD rate, YLL rate and DALY rate due to CVD were estimated to assess the burden of CVD in Zhejiang Province from 1990 to 2019. The changing trends in the burden of CVD were using annual percent change (APC) in Zhejiang Province from 1990 to 2019, and compared to China and global regions with different socio-demographic indexes (SDI). Results The YLL rate (APC=-0.50%, F=22.366, P<0.001) and DALY rate due to CVD (APC=-0.20%, F=5.212, P=0.030) appeared a tendency towards a decline in Zhejiang Province from 1990 to 2019, while the YLD rate showed a tendency towards a rise (APC=1.92%, F=1 117.891, P<0.001). The YLL rate (APC=-1.09%, F=56.871, P<0.001), YLD rate (APC=1.92%, F=922.541, P<0.001) and DALY rate (APC=-0.60%, F=28.974, P<0.001) appeared the same tendency among women relative to among the whole populations, while only the YLD rate showed a clear-cut change among men, appearing a tendency towards a rise (APC=1.82%, F=1 238.423, P<0.001). Both the YLL rate and DALY rate appeared a tendency towards a decline among subjects at all age groups, with the most significant reduction among subjects at ages of 50 to 69 years (YLL rate: APC=-4.40%, F=1 443.608, P<0.001; DALY rate: APC=-3.82%, F=1 519.452, P<0.001). Among all types of CVD, the highest burden was measured in cerebrovascular diseases, with a standardized DALY rate of 1 359.7/105, and the most remarkable reduction in the standardized DALY rate was seen in rheumatic heart diseases. The burden of CVD in Zhejiang Province was lower than that in China and the majority of the world, with consistent changing trends with that in China and global regions with different SDI. Conclusions The overall burden of CVD appeared a tendency towards a decline in Zhejiang Province from 1990 to 2019, which was in agreement with that in China and global regions with different SDI. A remarkable reduction in the burden of CVD was seen among women, residents at ages of 50 to 69 years and cases with rheumatic heart diseases.
Key wordscardiovascular disease    disease burden    disability-adjusted life years    years lived with disability    years of life lost
收稿日期: 2022-05-10      修回日期: 2022-07-14      出版日期: 2022-10-10
中图分类号:  R195  
通信作者: 李娜,E-mail:nli@cdc.zj.cn   
作者简介: 林永兴,硕士研究生在读,主管医师,主要从事公共卫生研究和管理工作
引用本文:   
林永兴, 刘足云, 李娜, 于村. 1990—2019年浙江省心血管疾病负担变化趋势[J]. 预防医学, 2022, 34(10): 1020-1025.
LIN Yongxing, LIU Zuyun, LI Na, YU Cun. Changing trends in burden of cardiovascular diseases in Zhejiang Province from 1990 to 2019. Preventive Medicine, 2022, 34(10): 1020-1025.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.10.010      或      http://www.zjyfyxzz.com/CN/Y2022/V34/I10/1020
[1] ROTH G A,MENSAH G A,JOHNSON C O,et al.Global burden of cardiovascular diseases and risk factors,1990-2019[J].J Am Coll Cardiol,2020,11(10):1-40.
[2] MASAEBI F,SALEHI M,KAZEMI M,et al.Trend analysis of disability adjusted life years due to cardiovascular diseases:results from the global burden of disease study2019[J/OL].BMC Public Health,2021,21(1)[2022-07-14].https://doi.org/10.1186/s12889-021-11348-w.
[3] 刘芳超,顾东风.中国心血管病防治的过去、现在和未来[J].心脑血管病防治,2020,20(1):2-4,17.
LIU F C,GU D F.Past,present and future of cardiovascular disease prevention and treatment in China[J].Prev Treat Cardio-Cereb-Vasc Dis,2020,20(1):2-4,17.
[4] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2021概要[J].中国循环杂志,2022,37(6):553-578.
The Writing Committee of the Report on Cardiovascular Health and Diseases in China.Report on cardiovascular health and diseases in China 2021:an updated summary[J].Chin Circ J,2022,37(6):553-578.
[5] 王浩,李娜,俞佳男,等.2003—2017年浙江省阿尔茨海默病发病和死亡趋势分析[J].预防医学,2022,34(3):227-231.
WANG H,LI N,YU J N,et al.Trends in incidence and mortality of Alzheimer's disease in Zhejiang Province from 2003 to 2017[J].Prev Med,2022,34(3):227-231.
[6] 张洁,费方荣,胡如英,等.浙江省慢性病主要危险因素的归因疾病负担研究[J].预防医学,2022,34(6):541-546.
ZHANG J,FEI F R,HU R Y,et al.Burden of disease attributable to main risk factors of chronic diseases in Zhejiang Province[J].Prev Med,2022,34(6):541-546.
[7] 宇传华,白建军.社会人口指数(SDI)的概念及其应用[J].公共卫生与预防医学,2020,31(1):5-10.
YU C H,BAI J J.The concept of Socio-Demographic Index(SDI)and its application[J].J Public Health Prev Med,2020,31(1):5-10.
[8] LIN X,XU Y,XU J,et al.Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories,1990-2017[J].Endocrine,2020,69(2):310-320.
[9] LIU S,LI Y,ZENG X,et al.Burden of cardiovascular diseases in China,1990-2016:findings from the 2016 Global Burden of Disease Study[J].JAMA Cardiol,2019,4(4):342-352.
[10] 王媛,曹新西,侯亚冰,等.1990和2017年中国与全球心血管病疾病负担研究[J].中国慢性病预防与控制,2020,28(1):10-13,19.
WANG Y,CAO X X,HOU Y B,et al.Study on Chinese and flobal cardiovascular diseases burden in 1990 and 2017[J].Chin J Prev Contr Chron Dis,2020,28(1):10-13,19.
[11] 亓建羽,王晨冉,刘咪,等.1990—2017年中国与不同社会人口学指数地区脑卒中疾病负担和危险因素的比较分析[J].中华预防医学杂志,2021,55(8):958-964.
QI J Y,WANG C R,LIU M,et al.Analysis on disease burden of stroke in China and the regions with different sociodemographic index from 1990 to 2017[J].Chin J Prev Med,2021,55(8):958-964.
[12] WANG H,NAGHAVI M,ALLEN C,et al.Global,regional,and national life expectancy,all-cause mortality,and cause-specific mortality for 249 causes of death,1980-2015:a systematic analysis for the Global Burden of Disease Study 2015[J].Lancet,2016,388(10053):1459-1544.
[13] LV J,YU C,GUO Y,et al.Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population[J].J Am Coll Cardiol,2017,69(9):1116-1125.
[1] 张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[2] 何晓庆, 罗进斌, 陈强, 魏芳. 2009—2021年金华市职业性尘肺病疾病负担分析[J]. 预防医学, 2023, 35(7): 620-624.
[3] 马昭君, 李伟伟, 董建梅, 周金意, 韩仁强, 秦绪成. 1990—2019年江苏省白血病疾病负担分析[J]. 预防医学, 2023, 35(4): 282-285,290.
[4] 黄文, 汤佳良, 陈康康, 黄敏钢, 陈奇峰. 绍兴市心血管疾病高危人群危险因素聚集分析[J]. 预防医学, 2023, 35(4): 298-302,330.
[5] 周洁, 谭自明, 茹凉. 1990年与2019年中国0~14岁儿童肿瘤疾病负担分析[J]. 预防医学, 2023, 35(3): 205-209.
[6] 黄文, 何亮, 傅玲娟, 翁丽霞, 张馨锡, 朱淑霞, 张阳辉, 陈奇峰. 动脉粥样硬化性心血管疾病高危人群血脂控制达标的影响因素研究[J]. 预防医学, 2023, 35(10): 834-839.
[7] 张洁, 费方荣, 胡如英, 龚巍巍, 钟节鸣. 浙江省慢性病主要危险因素的归因疾病负担研究[J]. 预防医学, 2022, 34(6): 541-546,554.
[8] 赵瑞, 黄胜楠, 肖暖. 中等强度有氧运动预防高胆固醇血症患者动脉粥样硬化性心血管疾病效果评价[J]. 预防医学, 2022, 34(1): 58-62.
[9] 韩雅斌, 陈向宇, 钟节鸣, 方乐, 梁明斌, 谢开婿, 张晓怡, 曹元, 陆凤, 徐春晓, 林静静. 桐乡市老年人群心血管疾病危险因素暴露及聚集分析[J]. 预防医学, 2021, 33(8): 812-814.
[10] 向静, 赵廷明, 李鑫, 张劲. 通江县35~75岁居民心血管疾病高危人群调查[J]. 预防医学, 2021, 33(6): 609-614.
[11] 蒙家嘉, 李辉, 王永, 纪威, 冯伟, 张瑞洁, 刘杨, 刘世炜, 韩丽媛. 2009—2018年宁波市居民心血管疾病死亡及早死所致疾病负担趋势分析[J]. 预防医学, 2021, 33(5): 451-456.
[12] 杨亮, 毛晓锋, 邓静, 陈娜. 2011—2019年长寿区居民食管癌死亡率及早死疾病负担趋势分析[J]. 预防医学, 2021, 33(5): 500-503.
[13] 陈欢, 刘永生,尹扬光. PM2.5对动脉粥样硬化的影响及机制[J]. 预防医学, 2021, 33(10): 1017-1021.
[14] 田沛茹, 张斯蒙, 倪萍, 刘晓冰, 孙秋红, 时景璞, . 彰武县和凤城市慢性下呼吸系统疾病早死所致疾病负担调查[J]. 预防医学, 2018, 30(9): 902-906.
[15] 汤晓菲,马志红. 航天系统职工血脂异常情况调查[J]. 预防医学, 2018, 30(9): 939-942.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed